Fusion Pharmaceuticals | Investor Presentation Deck | 26 slides · page 11 of 26
The slide uses a comparative structure to highlight the superiority of alpha particles in DNA damage and clinical logistics.
Pitch deck · why_now · argue_timing · dense density
Slide locked Sign in to view
Slide schematic 5/5
image 1/1 list 2/2 source-note 1/1 title 1/1
Components 5
illustration bullet bullet source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.